Nagma: Building an IVF Portfolio Is Not Just About Adding More Tests…
Nagma, Deputy Manager of Product Marketing at Max Lab, shared on LinkedIn:
“Building an IVF portfolio is not just about adding more tests. It’s about understanding where diagnostics can create value across the fertility journey.
From preconception and hormonal assessment to male fertility, genetic testing and reproductive health, IVF involves multiple clinical touchpoints, each with distinct diagnostic needs.
As a Product Manager, the opportunity is to look beyond individual tests and ask:
- What are the key clinical gaps?
- What do fertility specialists need at each stage?
- Which diagnostic solutions can support better clinical decisions?
- And where can we create sustainable business growth?
A strong IVF portfolio brings together clinical relevance, specialist needs, patient value and business opportunity.
For me, the focus is simple:
Not more tests. Better solutions for the right clinical need, at the right stage of the fertility journey.”
Stay informed with the latest updates in fertility and reproductive medicine on Fertility News.
-
Aug 22, 2026, 18:57Lowell Ku: What a Year for the Midwest Reproductive Symposium International
-
Aug 22, 2026, 18:52Does Age Really Affect Fertility? – Mayflower Women’s Hospital
-
Aug 22, 2026, 18:45New Research from the University of Hong Kong Examines Global Infertility Trends Among Women Aged 35-49
-
Aug 22, 2026, 18:37Devyanshi Dixit: Can We Detect Gynecologic Cancer Before Symptoms Appear?
-
Aug 22, 2026, 18:33Hema Divakar: A New Paradigm for Healthy Ageing in Women With POI and Early Menopause
-
Aug 22, 2026, 18:20Lowell Ku: Can What You Eat Affect Fertility?
-
Aug 22, 2026, 18:01Vikram Sinai Talaulikar: Long-Term Associations of Postmenopausal HRT Are Not “One-Size-Fits-All”
-
Aug 22, 2026, 17:57Lucy Froese: 36 Months of Negative Pregnancy Tests and Now I’ve Had 11 Years of Being Your Mum
-
Aug 22, 2026, 17:35Lamia Sayegh: The “Law of Series” in Reproductive Medicine